Implications of tumor location on subtypes of medulloblastoma

Pediatric Blood and Cancer

Volumn 60, Issue 9, 2013, Pages 1408-1410

  Teo, Wan Yee ^a   Shen, Jianhe ^a   Su, Jack Meng Fen ^a   Yu, Alexander ^a   Wang, Jian ^a   Chow, Wing Yuk ^a   Li, Xiaonan ^a   Jones, Jeremy ^a   Dauser, Robert ^a   Whitehead, William ^a   Adesina, Adekunle M ^a   Chintagumpala, Murali ^a   Man, Tsz Kwong ^a   Lau, Ching C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Medulloblastoma; Molecular subtypes; Pediatric; Tumor location

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN STEM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMISPHERE; HUMAN; INFANT; MALE; MEDULLOBLASTOMA; MONOSOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIGNAL TRANSDUCTION; STEM CELL; TUMOR LOCALIZATION;

MEDULLOBLASTOMA; MOLECULAR SUBTYPES; PEDIATRIC; TUMOR LOCATION;

ADOLESCENT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HEDGEHOG PROTEINS; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; RETROSPECTIVE STUDIES;

EID: 84880371001     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24511     Document Type: Article

References (36)

1. Thompson MC, Fuller C, Hogg TL, et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. JCO 2006; 24:1924-1931.
2. Kool M, Koster J, Bunt J, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 2008; 3:e3088.
3. Northcott PA, Korshunov A, Witt H, et al. Medulloblastoma comprises of four distinct variants. JCO 2011; 29:1408-1414.
4. Cho YJ, Tshemiak A, Tamayo P, et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. JCO 2011; 29:1424-1430.
5. Taylor MD, Northcott PA, Korshunov A, et al. Molecular subgroups of medulloblastoma: The current consensus. Acta Neuropathol 2012; 123:465-472.
6. Taylor MD, Liu L, Raffel C, et al. Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002; 31:306-310.
7. Wolter M, Reifenberger J, Sommer C, et al. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1997; 57:2581-2585.
8. Hallahan AR, Pritchard JI, Hansen S, et al. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res 2004; 64:7794-7800.
9. Romer JT, Kimura H, Magdaleno S, et al. Suppression of the SHH pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 2004; 6:229-240.
10. Oliver TG, Read TA, Kessler JD, et al. Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development 2005; 132:2425-2439.
11. Yang ZJ, Ellis T, Markant SL, et al. Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008; 14:135-145.
12. Schüller U, Heine VM, Mao J, et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008; 14:123-134.
13. Eberhart CG. Even cancers want commitment. Lineage identity and medulloblastoma formation. Cancer Cell 2008; 14:105-107.
14. Uziel T, Karginovb FV, Xie S, et al. The miR-1792 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci USA 2009; 106:2812-2817.
15. Zurawel RH, Chiappa SA, Allen C, et al. Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 1998; 58:896-899.
16. Huang H, Mahler-Araujo BM, Sankila A, et al. APC mutations in sporadic medulloblastomas. Am J Pathol 2000; 156:433-437.
17. Eberhart CG, Tihan T, Burger PC. Nuclear localization and mutation of beta-catenin in medulloblastomas. J Neuropathol Exp Neurol 2000; 59:333-337.
18. Clifford SC, Lusher ME, Lindsey JC, et al. Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 2006; 5:2666-2670.
19. Salaroli R, Tomaso TD, Ronchi A, et al. Radiobiologic response of medulloblastoma cell lines: Involvement of β-catenin? J Neurooncol 2008; 90:243-251.
20. Dakubo GD, Mazerolle CJ, Wallace VA. Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice. J Neuro Oncol 2006; 79:221-227.
21. Dahmen RP, Koch A, Denkhaus D, et al. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 2001; 61:7039-7043.
22. Gibson P, Tong Y, Robinson G, et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 2010; 468:1095-1099.
23. Borghesani PR, Peyrin JM, Klein R, et al. BDNF stimulates migration of cerebellar granule cells. Development 2002; 129:1435-1442.
24. Abraham H, Tornoczky T, Kosztolanyi G, et al. Cell formation in the cortical layers of the developing human cerebellum. Int J Dev Neurosci 2001; 19:53-62.
25. Wechsler-Reya RJ. Analysis of gene expression in the normal and malignant cerebellum. Recent Prog Horm Res 2003; 58:227-248.
26. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. PNAS 2005; 102:15545-15550.
27. Schüller U, Kho AT, Zhao Q, et al. Cerebellar "transcriptome" reveals cell-type and stage-specific expression during postnatal development and tumorigenesis. Mol Cell Neurosci 2006; 33:247-259.
28. Flora A, Klisch TJ, Schuster G, et al. Deletion of Atoh1 disrupts sonic hedgehog signaling in the developing cerebellum and prevents medulloblastoma. Science 2009; 326:1424-1427.
29. Ayrault O, Zhao H, Zindy F, et al. Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells. Cancer Res 2010; 70:5618-5627.
30. Zhao H, Ayrault O, Zindy F, et al. Post-transcriptional down-regulation of ATOH1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes Dev 2008; 22:722-727.
31. Ben-Arie N, Bellen HJ, Armstrong DL, et al. Math1 is essential for genesis of cerebellar granule neurons. Nature 1997; 390:169-172.
32. Polkinghorn WR, Tarbell NJ. Medulloblastoma: Tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Nat Clin Pract Oncol 2007; 4:295-304.
33. Brandes AA, Franceschi E, Tosoni A, et al. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol Hematol 2009; 71:165-179.
34. Padovani L, Sunyach MP, Perol D, et al. Common strategy for adult and pediatric medulloblastoma: A multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 2007; 68:433-440.
35. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114:97-109.
36. Korshunov A, Remke M, Werft W, et al. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. JCO 2010; 28:3054-3060.